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Abstract
Background: Many studies investigate HPV vaccine acceptability, applying health behavior theories to identify
determinants; few include real uptake, the final variable of interest. This study investigated the utility of the Health
Belief Model (HBM) in predicting HPV vaccine uptake in Kenya, focusing on the importance of promotion, probing
willingness to vaccinate as precursor of uptake and exploring the added value of personal characteristics.
Methods: Longitudinal data were collected before and after a pilot HPV vaccination program in Eldoret among
mothers of eligible girls (N = 255). Through pathway modeling, associations between vaccine uptake and the
HBM constructs, willingness to vaccinate and adequate promotion were examined. Adequate promotion was
defined as a personal evaluation of promotional information received. Finally, baseline cervical cancer awareness
and socio-demographic variables were added to the model verifying their direct, mediating or moderating effects
on the predictive value of the HBM.
Results: Perceiving yourself as adequately informed at follow-up was the strongest determinant of vaccine uptake.
HBM constructs (susceptibility, self-efficacy and foreseeing father’s refusal as barrier) only influenced willingness to
vaccinate, which was not correlated with vaccination. Baseline awareness of cervical cancer predicted uptake.
Conclusions: The association between adequate promotion and vaccination reveals the importance of triggers
beyond personal control. Adoption of new health behaviors might be more determined by organizational variables,
such as promotion, than by prior personal beliefs. Assessing users’ and non-users’ perspectives during and after
implementing a vaccination program can help identifying stronger determinants of vaccination behavior.
Keywords: HPV vaccination, Health Belief Model, Cohort, Kenya, Pathway modeling
Background
Cervical cancer poses a high burden on women’s health
in Kenya due to its high incidence and the poor prognosis
of most patients. This elevated incidence rate is related to
the high prevalence of HIV, the low screening coverage in
Kenya (only 3.2 % of all women are screened every 3 years),
and the absence of the Human Papillomavirus (HPV)
vaccine in the national vaccination program [1]. If the
HPV vaccine becomes available in Kenya, it would provide
women on-going protection against several high-risk HPV
types [2–4].
However, before adding the HPV vaccine to a national
vaccination program, a situation analysis is valuable to
prepare the introduction of the vaccine in terms of costs
and infrastructure but also to assess readiness among the
population [5, 6]. Worldwide, many studies have investi-
gated girls’ caregivers’ willingness to vaccinate, often before
the vaccine was introduced. While acceptability is usually
high, doubts about the safety and efficacy of the vaccine
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are common [7–11]. In certain subpopulations, there is
also the belief that the vaccines might promote promis-
cuity although past research does not support these
claims [12, 13].
Frequently, these acceptability studies apply (health)
behavior theories that include a variety of factors (e.g. at-
titudes, beliefs, perceived barriers) which are believed to
influence the likelihood of a certain action [14, 15]. By
investigating these theories’ constructs, researchers aim
to identify determinants of vaccine uptake and refusal to
incorporate them in vaccination strategies. An example
of such theory is the ‘Health Belief Model’ (HBM), an
established model often used to identify determinants of
vaccination behavior [14, 16]. The original HBM indicates
that in order for an individual to take action (e.g. to
vaccinate your daughter), this person would have to (1)
perceive the disease at least as ‘moderately severe’; (2)
perceive a susceptibility or vulnerability to the disease;
(3) believe that there are benefits in taking the preventive
action; and (4) not perceive major barriers obstructing the
action. According to the theory, the likelihood to action
increases when the perceived benefits outweigh the per-
ceived barriers [17]. Additionally, the HBM is often ex-
tended with two more constructs: (5) self-efficacy,
indicating the ‘expectancies about one’s own competence
to perform the behavior’ and (6) cues to action (CTA),
i.e. ‘the specific stimuli necessary to trigger the decision-
making process’ [18–20].
Brewer et al. (2007) and Cunningham et al. (2014) have
reviewed HPV vaccine acceptability studies focusing on
the HBM constructs in the USA and Africa respectively
[14, 21]. The former review included twenty eight studies,
the latter fourteen (among ten countries). Perceived sus-
ceptibility reported in African studies was not always high
which might have been caused by misunderstandings such
as believing the disease is inherited. In general, own risk
was considered lower than a daughter’s risk of HPV infec-
tion or cervical cancer. While studies in the USA revealed
a positive relation between susceptibility and acceptability
[14] Cunningham et al. (2014) reported either no correl-
ation [22] or also a positive one [21, 23]. Among all stud-
ies, the majority of the participants agreed that cervical
cancer is a serious illness (perceived severity) [14, 21].
While two studies, in Botswana and Ghana [22, 23], de-
tected an association between HPV vaccine acceptability
and perceived severity, the other studies were not conclu-
sive. Perceived effectiveness of the HPV vaccine was the
main benefit investigated while in terms of barriers cost
and safety concerns were discussed, among others. The
link with acceptability remains again unclear for both con-
structs: reported barriers do not necessarily deter accept-
ability and trusting the vaccine’s efficacy does not always
lead to higher willingness to vaccinate [14, 21]. Finally,
cues to action indicated by American studies included
physician’s recommendation and school requirement, and
although this was only reported by few studies, a positive
association with acceptability was found [14]. In the Af-
rican studies, cues to action also enclosed endorsement
from the government and acknowledgement by commu-
nity members (associations with acceptability were not in-
vestigated) [21]. In general, both reviews showed that the
HBM constructs influence people’s willingness to vaccin-
ate against cervical cancer. However, they do caution for
overreliance on the results: since almost all studies in-
cluded were cross-sectional no causal relations could be
identified [14, 21].
It is generally agreed upon that there is a need to fur-
ther test health behavior theories as to justify their use
in promotion and vaccination interventions and to verify
their applicability in different settings. It is known that
the utility of the HBM varies according to the type of be-
havior that is predicted (preventive versus curative) and
the health condition to be tackled (prevalence, morbidity
and mortality of the disease in the study setting). Further-
more, cultural or socio-demographic variables might affect
the predictive value of the model [19, 24, 25]. According
to Janz and Becker, socio-demographic characteristics can
have both direct and modifying effects on the (associations
between) HBM constructs [19]. With regard to HPV
vaccination, characteristics such as cervical cancer know-
ledge, age of the daughter or conservative thinking often
affect acceptability [14, 15]. However, there is no clear de-
scription on which are most important and there is no
agreement on how such personal characteristics fit the
HBM (e.g. directly, mediated, or moderating effects).
Similarly, CTA are poorly studied. In theory, two types
are distinguished: internal cues, such as symptoms, and
external cues, such as advice from others or a promotional
campaign. While these conventional definitions seem
straightforward, measuring CTA remains a challenge
given that “a cue can be as fleeting as a sneeze or the
barely conscious perception of a poster” [20]. In addition,
to truly be a factor that influences behavior, the trigger
does not only have to reach the person, it also needs to
prompt adoption of the behavior [26]. So depending on
an individual’s perception, a certain cue might be
interpreted as a trigger or not. Therefore, we propose
to include a personal assessment of a cue such as pro-
motion, expanding CTA to receiving and personally
evaluating the motivator, e.g. by using the questions ‘did
you receive an invitation for the cervical cancer vaccin-
ation program?’ and ‘did you feel well informed?’.
Finally, another point of discussion about the operatio-
nalization of the HBM is the outcome measure. While
the original HBM had actual behavior as outcome (e.g.
‘vaccine uptake’), many studies apply the HBM to identify
factors influencing acceptability or intention, considering
these intervening variables as a precursor of behavior
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[14, 15, 24]. However, attitudes and intentions do not
always translate into health behavior [27]. Research
should therefore not only include antecedents but also
the actual behavior as to distinguish factors that influence
willingness versus those that inhibit or drive true behavior.
Moreover, theories should be tested through longitudinal
studies in which the influence of past behavior – often the
biggest predictors of future behavior – is, if possible, ex-
cluded [24, 25]. Given that HPV vaccination in Kenya is
not yet widespread, a pilot vaccination program offered
the opportunity to measure the predictive value of the
HBM constructs in this context and to explore the add-
itional value of innovative variables.
The purpose of the present longitudinal study was to
examine the applicability of the HBM to predict HPV
vaccine uptake in Kenya. This general aim is specified
into three underlying research objectives. First, we ex-
amined whether the HBM constructs predicted vaccine
uptake, including a subjective evaluation of promotion.
Second, we evaluated the validity of adding willingness
to vaccinate to the HBM as mediator of uptake. Lastly, a
hypotheses generating component was added, examining
the direct- and modifying effects of personal characteris-
tics on the (associations between the) HBM constructs.
Methods
Pilot HPV vaccination program
Through the Gardasil Access Program (GAP), Moi Teach-
ing and Referral Hospital (MTRH – Eldoret) received
9000 doses of the HPV vaccine. Ten out of forty-two pub-
lic primary schools in Eldoret Municipality were randomly
selected to participate in this pilot vaccination program.
All girls in classes 4 to 8 of these schools (i.e. around 4000
pupils, approximately 9–13 years old), were eligible to re-
ceive three free doses of the quadrivalent vaccine. The
vaccination was provided in MTRH, located in the center
of Eldoret, while promotion was organized at school:
health care providers informed the teachers who then
passed on the information to students and parents. Im-
plementation of such promotional activities differed from
school to school, from parents meetings at school to
teachers asking their pupils to notify their parents about
the vaccination opportunity. The baseline and follow-up
study took place in March 2012 and May 2013 respect-
ively, i.e. right before and after the pilot program, which
ran from May 2012 till March 2013 [28, 29].
Participants and procedures
For this study, a random selection of girls eligible for
vaccination were given an invitation letter for the face-
to-face baseline interview, addressed to their mother. The
number of girls per school was in proportion to the size of
the school. Contact information requested at baseline was
used to make an appointment for the follow-up interview:
participants were contacted by phone, or the interviewers
went looking for them at the description of the living-
place or at school. If those contacted by phone were not
able to participate in the complete, face-to-face follow-up
interview, they were invited to answer by phone whether
or not their daughter had received the HPV vaccine.
(Figure 1) The women were interviewed in Swahili or
English, depending on their preference.
During the baseline interview, mothers were given basic
information and had the opportunity to ask questions re-
garding cervical cancer, HPV vaccination and the upcom-
ing program in order to enable them to make an informed
decision. More detailed information about the planned
vaccination effort was meant to be provided to all parents
of all eligible girls by promotional activities at school. To
achieve consistency in the interviews, standard guidelines
for introductions, interviews, and informed consent re-
quests were practiced [28, 29].
Fig. 1 Flow diagram of the recruitment and response of study
participants
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Measures
Outcome variable uptake
The main outcome of the study was the actual behavior,
i.e. HPV vaccine uptake, reported by the participants
during the follow-up survey (i.e. when the pilot HPV
vaccination program had closed). Uptake was reported
per dose but assessed as a dichotomous variable (0 = re-
ceived no HPV vaccine doses, 1 = received one or more
doses of the HPV vaccine) given that few vaccinated girls
had not completed the required scheme of three doses.
HBM constructs
All constructs were measured at baseline (before the
pilot HPV vaccination program started). Perceived sever-
ity, susceptibility and three barriers (‘foreseeing father’s
refusal’, ‘doubting vaccine efficacy’ and ‘perceiving lack of
information’) were assessed directly, while other HBM
constructs (self-efficacy, trusting the health benefit of the
vaccine and the two barriers ‘having safety concerns’ and
‘foreseeing time constraints’) were measured through sev-
eral items (Table 1). All items were derived from the
Table 1 Complete list of items used to assess the health belief model (HBM) constructs and willingness
Constructs baseline/follow-upa Item wording (response options) # items αb
Severity baseline How serious would it be if your daughter would have cervical cancer?
(1 = not serious at all–5 = very serious)
1 n/a
Susceptibility baseline How likely is it that your daughter would develop cervical cancer in the
future? (1 = very unlikely–5 = very likely)
1 n/a
Benefit health baseline You would vaccinate your daughter because: 3 .888
The vaccine will protect her health. (1 = strongly disagree–5 = strongly agree)
The vaccine will protect her reproductive health. (1 = strongly disagree–5 =
strongly agree)
The vaccine will prevent her from having cervical cancer. (1 = strongly
disagree–5 = strongly agree)
Barriers baseline You would not vaccinate your daughter because:
Lack of
information
You need more information first (1 = strongly disagree–5 = strongly agree) 1 n/a
Doubt
vaccine efficacy
You doubt that the vaccine will truly prevent cervical cancer and genital warts
(1 = strongly disagree–5 = strongly agree)
1 n/a
Time
constraints
You think vaccination always takes a lot of time. (1 = strongly disagree–5 =
strongly agree)
2 .791
You think it’s inconvenient that she needs 3 doses. (1 = strongly disagree–5 =
strongly agree)
Safety
concerns
You think it might have unknown future side effects. (1 = strongly disagree–5 =
strongly agree)
3 .882
You think it might interfere with her fertility. (1 = strongly disagree–5 = strongly agree)
You’re afraid the vaccine will not be administered safely (clean needles).
(1 = strongly disagree–5 = strongly agree)
Father’s
refusal
You think your partner or her father won’t approve it. (1 = strongly disagree–5 =
strongly agree – 0 = no current relationship)
1 n/a
Self-efficacy baseline Are you confident that you could let your daughter get vaccinated if you wanted?
(1 = not confident at all–5 = very confident)
2 .762
For you, if you want your daughter to be vaccinated against cervical cancer, that
would be. (1 = very difficult–5 = very easy)
Adequate promotionc follow-up
Personal level Did you feel well informed regarding the cervical cancer vaccination program?
(0 = no, 1 = yes)
1 n/a
School level School average of adequate promotion at personal level 1 n/a
Willingness to vaccinate baseline Would you vaccinate your daughter against cervical cancer? (1 = very unlikely–5 =
very likely)
2 .901
Will you let you daughter get vaccinated against cervical cancer through this
program? (1 = very unlikely–5 = very likely)
aMeasure obtained from baseline or follow-up interview
bCronbach’s alpha (α) indicating the reliability
cParticipants were asked if that had heard about the HPV vaccination program at the hospital after being informed during the baseline interview. If yes, they were
asked whether or not they had felt well-informed
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literature, and benefits and barriers were chosen based on
previous research in similar contexts [7, 15, 23, 30, 31].
Mediator willingness to vaccinate
This variable was composed of the sum score of 2 baseline
items, i.e. ‘Would you vaccinate your daughter against
cervical cancer?’, and, ‘Will you let you daughter get vacci-
nated against cervical cancer through this program?’
(Table 1).
Adequate promotion
During the follow-up interview, people were asked whether
they had heard of the HPV vaccination program through
school after the baseline interview and if so, whether they
felt well-informed regarding the cervical cancer vaccination
program. Through this we assessed if promotional activ-
ities had reached the women (cfr. CTA) and how the mes-
sages were perceived. Adequate promotion was thus a
subjective evaluation of outreach messages. Since promo-
tion differed among schools, we created a variable reflect-
ing the level of adequate promotion in each school (i.e. the
average of being well-informed at personal level for each
school). This variable captured the ‘school effect’, i.e. the
different levels of promotion among the different schools,
while the original variable measured being well-informed
at personal level (Table 1).
Personal characteristics
We included ten personal factors and socio-demographic
variables to explore their potential direct and modifying
effects on the HBM constructs, willingness and uptake: (1)
age of the participant; (2) age of the daughter; (3) class of
the daughter; (4) marital status of the participant; (5)
number of children (<18 years) in the household; (6) ever
heard of cervical cancer (awareness participant); (7) years
of schooling of the participant; (8) origin of the partici-
pant: whether the participant grew up in an urban or rural
area; (9) religion of the participant; (10) socio-economic
status (SES): a scale representing the quality of the build-
ing materials used for the house. All these factors were ob-
tained from the baseline survey [28]. For some of the
items (marital status, origin, and religion) answer options
in the questionnaire were merged based on preliminary
analysis and to facilitate interpretations.
Statistical analyses
To compare participants who completed versus partici-
pants who did not complete the follow-up survey, we per-
formed an univariate analysis of variance (ANOVA).
Cronbach’s alpha was calculated to check for internal
consistency of constructs’ items (>0.75 was considered
acceptable) [32]. Personal characteristics with less than
5 % missing data were imputed using the expectation
maximization method (EM), after establishing that the
data were missing completely at-random (Little’s MCAR
χ2(259) = 257.583, p = .513). If a background characteristic
had more than 5 % missing values, only data from partici-
pants without missing values was used to build models in-
cluding that variable. Pathway modeling was applied to
investigate the three specific research objectives.
The first research objective, evaluating whether the
HBM predicts HPV vaccine uptake in a Kenyan context,
was examined with two models: Model 1, containing the
HBM constructs measured at baseline (perceived severity,
susceptibility, benefits, barriers, and self-efficacy) and
Model 2, adding adequate promotion, measured at follow-
up, as predictor for uptake.
The second research objective, assessing the validity of
adding willingness to vaccinate to the HBM as mediator
of uptake, was examined with Model 3. This model con-
tained all the predictors of Model 2. However, the baseline
HBM constructs were specified to predict willingness, and
willingness and adequate promotion to predict uptake.
Finally, we examined the direct and modifying effects
of all ten personal characteristics on the (associations
between the) HBM constructs. To do so, we applied an
exploratory modeling procedure. First, all factors were
independently added as direct (e.g. heard of cervical
cancer→ uptake), mediated (e.g. religion→ severity→
willingness), or moderating effect (e.g. age of the
daughter→willingness, with barrier ‘father’s refusal’
moderating the effect) in Model 3 (Additional file 1:
Table S1). Next, Model 4 was fitted containing all sig-
nificant effects from this exploratory procedure in addition
to the predictors specified in Model 3. To correct for mul-
tiple testing we applied a more conservative critical p-value
of 0.01.
Models were fitted using the weighted least-squares
estimator with mean and variance adjustment (WLSMV;
because of the dichotomous primary outcome variable
(uptake)) [33]. To ensure reliable interpretation of the
results, the underlying assumptions of SEM were checked
for all variables included in the models (multicollinearity,
linearity in the logit, missing data, and outliers). Further-
more, the nine baseline HBM constructs were allowed to
correlate in all models. In addition, all models were evalu-
ated by assessing the efficacy of each model in predicting
willingness and uptake (R2). Since uptake is a dichotomous
variable, R2 is estimated assuming that the categorical indi-
cator is a coarse categorization of a normally distributed
underlying dimension. Furthermore, the fit of the path
models (Model 3-Model 4) was assessed with the chi-
square overall goodness-of-fit statistic (CHISQ), the com-
parative fit index (CFI), the Tucker-Lewis Index (TLI), the
root-mean-square error of approximation (RMSEA), and
the weighted root mean square residual (WRMR). RMSEA
values <0.06, CFI >0.97, TLI >0.9 and WMSR < 1.0 indicate
close fit [34, 35]. MPlus was used to perform the analyses.
Vermandere et al. Globalization and Health  (2016) 12:72 Page 5 of 13
Sample size
The necessary sample size was calculated for a previous
study and data analysis [28]. With 255 observations, the
data set is however also adequate for SEM (i.e. minimum
200 observations) [34].
Ethics, consent and permissions
The Institutional Research and Ethics Committee of
Moi Teaching and Referral Hospital, and the Ethical
Committee of Ghent University Hospital approved this
study (approval numbers FAN:IREC 000771 and
B670201212980-B670201317007, respectively). Written
informed consent was requested before the baseline inter-
view, and this was verbally confirmed before the follow-up
interview. Participants received no incentives for partici-
pation in the baseline survey, while a financial compensa-
tion of 200 Kenyan Shilling (US $2.34) was given for the
time and effort they invested in a second face-to-face
interview [28].
Results
Participation
A flow diagram of recruitment and response of partici-
pants within this longitudinal research design is presented
in Fig. 1. Of the 472 invited participants, only 287 agreed
to participate in the baseline survey (61 %), while 256 of
them (89 %) agreed to participate in the follow-up survey.
Non-completers (n = 31) were similar to completers
(n = 256) on all HBM constructs and personal characteris-
tics with only one exception. Compared to completers,
the non-completers scored slightly lower on self-efficacy
(t(285) = 2.547, p = 0.011).
Of the 256 participants of the follow-up survey, 8 %
(n = 20) only provided the information about their daugh-
ter’s vaccination status through the short telephone sur-
vey; data on adequate promotion is missing for them.
One participant was deleted from analysis because she
did not report whether her daughter was vaccinated
(Nanalyses = 255).
The baseline HBM constructs did not have any missing
values and Cronbach’s alpha was found to be acceptable
(>.75) for all HBM constructs (Table 1) [32].
Descriptive analysis
Of the 255 participants included in the analyses, the
average willingness to vaccinate was 4.4 (range 1–5).
>This positive attitude towards the HPV vaccine was
reflected in the baseline measured HBM constructs: the
average perceived severity was 3.8 (range 1–5), average
perceived susceptibility was 3.7 (range 1–5), average per-
ceived health benefits was 4.6 (range 1–5). Furthermore,
proposed barriers were not often agreed on. The average
scores on the barriers (range 1–5) were: lack of informa-
tion 3.5 (range 1–5), doubting vaccine efficacy 2.4, time
constraints 1.4, safety concerns 2.6, and father’s refusal
1.5. Lastly, the average score of mothers’ self-efficacy
was 4.3 (range 1–5) (Table 2).
In the follow-up survey, 37 % of the participants men-
tioned they had not been well-informed about the program
(adequate promotion = 0). However, the average percentage
of people mentioning this lack of promotion fluctuated per
school (18 % - 83 %). By the end of the program, 31 % had
their daughter vaccinated against cervical cancer with one
dose or more (72 % of them had received 3 doses). Means,
standard deviations, and correlations across HBM con-
structs, willingness to vaccinate, adequate promotion
and vaccine uptake are provided in Table 2.
Of all personal characteristics, four had less than
5 % missing values (age of the daughter, age of the par-
ticipant, cervical_cancer_awareness and origin_of_the_
participant) and one had more than 5 % (years of school-
ing of the participant). The characteristics of the partici-
pants can be summarized as follows: the average age of
the mothers was 36 (range 21–59); the average age of the
daughter was 12 (range 8–18); the average class of the
daughter was 6 (range 4–8); 76 % of the participants had a
partner (married or living together) while the remaining
24 % was either separated, widowed or never had a part-
ner (i.e. currently single); 3.5 (range: 1–7) was the average
number of children in the household; 60 % had at least
heard of cervical cancer (awareness); the average years of
schooling of the participant was 8.4 (range: 0–16); 60 % of
the participants grew up in a Kenyan city, 38 % were ori-
ginally from the countryside and 1 % was from outside
Kenya (the latter 2 were grouped for analysis); 80 % of the
participants indicated to be Protestant, 15 % Catholic, 4 %
Muslim, 1 % other or no religion (for analyses this was
combined into Muslim (4.3 %) vs. non-Muslim (95.7 %));
and the average score of the quality of the building ma-
terials of the house was 4.6 (range 2–7) (Table 3).
The health belief model
Research objective 1: Application of the HBM
First, to examine how the nine HBM constructs measured
at baseline predicted uptake, we fitted Model 1 (Fig. 2a).
The nine predictors only accounted for 8 % of the variance
in uptake. The only significant predictor of uptake was
self-efficacy (standardized path coefficient self-efficacy
β = .31).
In Model 2 (Fig. 2b) it was examined whether addition
of the two adequate promotion variables increased the
explained variance of uptake. The two included adequate
promotion variables, adequate promotion at the individ-
ual level (β = .33) and adequate promotion at the school
level (β = .49), increased the explained variance of uptake
to 49 %. None of the other predictors were significantly
related to uptake.
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Research objective 2: Willingness as a predictor for uptake
Model 3 (Fig. 3) assessed the validity of adding willing-
ness to vaccinate to the HBM as mediator of uptake. In
Model 3, the nine baseline HBM constructs were speci-
fied to predict willingness, and willingness and ad-
equate promotion to predict uptake. Model 3 provided
a close fit to the data [CHISQ(11) = 7.276, p = .776;
RMSEA = .00; CFI = 1; TLI = 1.081; WRMR = 0.51]. Over-
all, 47 % of the variance in uptake and 41 % of the variance
in willingness was explained by predictors in the model.
Willingness was not significantly associated to uptake. In
contrast, adequate promotion at the individual level
(β = .34) and at the school level (β = .46) were significantly
related to uptake. Susceptibility (β = .25), the barrier ‘fore-
seeing father’s refusal’ (β = −.15), and self-efficacy (β = .41)
were significantly related to willingness.
Research objective 3: Influence of personal characteristics in
the HBM
Finally, in Model 4 we examined the direct and modifying
effects of personal characteristics on the (associations
between the) HBM constructs. A priori, an exploratory
modeling procedure was applied examining the effects
(1. direct, 2. mediated, 3. moderating) of each personal
parameter individually. Of the direct effects of the char-
acteristics, only cervical cancer awareness was found to
be significantly (p < .01) related to uptake. Next, the ef-
fect of religion (i.e. being Muslim) on willingness was
found to be significantly mediated (p < .01) by: severity,
susceptibility, self-efficacy, ‘trusting the health benefit’,
and the barriers ‘foreseeing time constraints’ and
Table 2 Correlations, means, standard deviations, and ranges of Health Belief Model constructs
Variable 1 2 3 4 5 6 7 8 9 10 11 12 13
Correlation coefficients:
1. vaccine uptake 1.00
2. Willingness to vaccinate .13* 1.00
3. Severity .00 .25* 1.00
4. Susceptibility .02 .38* .21* 1.00
5. Benefit health .08 .34* .31* .06 1.00
6. Barrier lack of
information
.02 .02 .06 -.09 .22* 1.00
7. Barrier doubt vaccine
efficacy
-.01 -.15* .03 -.14* -.07 .38* 1.00
8. Barrier time constraints -.03 -.21* -.18* -.08 -.29* -.02 .10 1.00
9. Barrier safety concerns .00 -.15* .03 -.17* .02 .37* .79* .10 1.00
10. Barrier father’s refusal -.08 -.39* -.09 -.28* -.13* .09 .26* .19* .29* 1.00
11. Self-efficacy .18 .54* .27* .15* .56* .11 -.03 -.32* -.02 -.32* 1.00
12. Adequate promotion:
individual
.36* .14* .03 .05 .04 -.07 .06 -.05 .05 -.17* .11 1.00
13. Adequate promotion:
school
.36* .16* .07 .07 .09 .02 .09 -.07 .10 -.08 .15* .42* 1.00
Meana 31 % 4.43 4.82 3.79 4.60 3.51 2.37 1.38 2.55 1.54 4.33 62 % .62
SD .46 .86 .59 1.03 .58 1.47 1.35 .56 1.29 1.43 .81 .47 .20
Range 0/1 1-5 1-5 1-5 1-5 1-5 1-5 1-4 1-5 0-5 1-5 0/1 .18-.83
N = 255
a Means of dichotomous variables are replaced by proportions of ones observed
Table 3 Baseline characteristics of the participants (n = 255)
Meana Range Standard
deviation
Characteristics of the mother
Age of the mother 36 21-59 6.8
Mother has a partner 76 % 0-1 0.4
Years of schooling 8.4 0-16 3.5
Raised in a urban area (vs rural) 60 % 0-1 0.5
Cervical cancer awareness at baseline 60 % 0-1 0.5
Islamic (vs. other religion) 4.3 0-1 0.2
Characteristics of the household
Quality of the house 4.6 2-7 0.9
Number of children 3.5 1-7 1.3
Characteristics of the daughter
Age of the daughter 12 8-18 2.0
Class of the daughter 6 4-8 1.4
aMeans of dichotomous variables are replaced by proportions of ones observed
Vermandere et al. Globalization and Health  (2016) 12:72 Page 7 of 13
a b
Fig. 2 Health Belief Model to predict HPV vaccine uptake without adequate promotion (a Model 1) and with adequate promotion (b Model 2).
Numbers represent the significant (p < .05) standardized parameters (β). Thin lines without numbers represent non-significant parameters in the
model. R2 represents the explained variance of the dependent variable. (N = 255)
Fig. 3 Health Belief Model to predict HPV vaccine uptake fully mediated by willingness to vaccinate [CHISQ(11) = 7.276, p = 0.776; RMSEA = 0.00;
CFI = 1; TLI = 1.08; WRMR = 0.51]. Health Belief Model to predict HPV vaccine uptake fully mediated by willingness to vaccinate (Model 3). Numbers
represent the significant (p < .05) standardized parameters (β). Thin lines without numbers represent non-significant parameters in the model.
R2 represents the explained variance of the dependent variable. (N = 255)
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‘foreseeing father’s refusal’. Furthermore, the age of the
daughter was found to have a significant (p < .01) effect on
the relation between barrier ‘foreseeing father’s refusal’
and willingness. Lastly, marital status and SES had a sig-
nificant (p < .01) effect on the relation between susceptibil-
ity and willingness (Additional file 1: Table S1).
In Model 4 (Fig. 4) we added all these significant ef-
fects of the personal characteristics to Model 3. To avoid
estimation errors, only the strongest of the interactions
with susceptibility (i.e. susceptibility*marital status) was
incorporated in the model. The predictors in the model
explained 48 % of the variance in willingness and 52 %
of the variance in uptake; willingness was not significantly
associated with uptake (p = 0.185). Religion was found to
be significantly (p < .05) related to severity (β = −.23), sus-
ceptibility (β = −.13), self-efficacy (β = −.15), ‘trusting the
health benefit’ (β = −.20), and the barriers ‘foreseeing
time constraints’ (β = .19), and ‘foreseeing father’s refusal’
(β = .24). Next, susceptibility, the barrier ‘foreseeing fa-
ther’s refusal’, and self-efficacy were related to willing-
ness (β = .46, β = −.63, β = .39 respectively). Furthermore,
two interactions were significantly related to willingness:
marital status*susceptibility (β = −.27), and age of the
daughter*barrier ‘foreseeing father’s refusal’ (β = .40).
Lastly, in addition to adequate promotion at individual
level (β = .30) and at school level (β = .51), baseline cer-
vical cancer awareness was significantly related to up-
take (β = .20). Acceptable goodness of fit was obtained
with Model 4 [CHISQ (85), p = 0.0001, RMSEA = .052;
CFI = 0.920; TLI = 0.836. WRMR = 0.910].
Discussion
The Health Belief Model is an established health theory
often used as framework to develop health interventions.
In this model, constructs concerning severity, suscepti-
bility, benefits, barriers and self-efficacy are considered
important determinants of the health related behavior
[17–20]. This study examined whether the HBM can be
applied to predict HPV vaccine uptake in Kenya, a coun-
try with little research on HPV vaccine acceptability and
uptake.
Research objective 1: Application of the HBM, including
adequate promotion
A first remarkable result of this study was the large dif-
ference between Model 1 and Model 2: adding adequate
promotion, at both personal and school level, increased
the predictive value from 8 to 49 %. The strong
Fig. 4 Health Belief Model to predict HPV vaccine uptake including personal characteristics and mediated by willingness [CHISQ (85), p = 0.0001,
RMSEA = 0.052; CFI = 0.920; TLI = 0.84; WRMR = 0.910]. Health Belief Model to predict HPV vaccine uptake including personal characteristics and
fully mediated by willingness to vaccinate (Model 4). Numbers represent the significant (p < .05) standardized parameters (β). Thin lines without
numbers represent non-significant parameters in the model. R2 represents the explained variance of the dependent variable. (N = 255)
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correlation between adequate promotion and HPV vac-
cination is not surprising since many studies have
stressed the importance of triggers such as health pro-
vider’s recommendation [16, 36–38]. Our results might,
however, overestimate the strength of the association be-
cause of two reasons: 1) Unlike the other HBM constructs,
adequate promotion is measured at follow-up, i.e. when
uptake was also recorded, which means the direction of
the correlation is indeterminable, and 2) adequate promo-
tion reflects the quality of the promotion from the perspec-
tive of the participant. This means that two participants
who received the same information through the same
channel, might report adequate promotion differently,
most possibly in agreement with the vaccination status
of their daughter. Nevertheless, the strong correlation
cannot be overlooked: whether or not the daughter re-
ceived the vaccine was highly associated with obtaining
sufficient information. Furthermore, it is important to
mention that before adequate promotion was added to the
model, self-efficacy was the only HBM construct found to
have a positive correlation with vaccine uptake. This
clearly shows that besides an external trigger, participants
still need to perceive themselves capable in performing
the action, i.e. taking their daughter for a vaccination, and
therefore justifies addition of this construct to the HBM.
The fact that none of the other HBM constructs pre-
dicted uptake is surprising, yet there are several expla-
nations possible. First of all, threat (severity and
susceptibility) and ‘trusting the health benefit’ are very
skewed, making it more difficult to identify relations.
All participants considered cervical cancer as a very
severe disease which their daughter was (very) likely
to get, and they all were driven to protect their daugh-
ter’s health. Given that cancer is perceived severe and
deathly worldwide, it is a not a startling ascertainment
that also in Kenya, where treatment remains inaccess-
ible for many people, cervical cancer is considered a
serious disease. Moreover, severity has often been identi-
fied as a construct with less predictive value, definitely
with regards to preventive behavior [19, 39–41]. With re-
gard to susceptibility, one can wonder how well parents
are capable to estimate future (sexual) behavior and well-
being of their daughter. Do they overestimate their daugh-
ter’s vulnerability because of concern and anxiety? Such
emotions clearly also influence decision-making yet they
are not included in cognitive theories [20, 42]. Finally, the
current HIV epidemic, affecting all layers of society, might
have increased their sense of vulnerability regarding sexual
transmittable infections.
Barriers are very often among the strongest predictors
of behavior [19, 40], but in our study none were associated
with uptake. Again, little variance was found: almost all
participants trusted the efficacy and safety of the vaccine
and worried little about time boundaries or objection of
their partner. Social desirability and poor assessment skills
of the participants might be at the base of these highly
pro-vaccine statements. On the other hand, other studies
found similar results and the worldwide success of child-
hood vaccination might also encourage Kenyan women to
truly trust and welcome the new HPV vaccine, as other
studies have also found [7–9]. Future studies can explore
this more in-depth e.g. by applying more multiple item
measures, since they have better predicting power, or by
assessing users’ and non-users’ perspectives during and
after program implementation. While this latter approach
would not contribute to identifying causal relations it
could help to explore and identify other determinants
than the HBM constructs given that in this study we
found little or no support for the HBM in the current con-
text of cervical cancer vaccination in Kenya.
Research objective 2: Willingness as a predictor for
uptake
Adding willingness to vaccinate as mediator of uptake
lowered the predictive value of the HBM from 49 to
47 %. Moreover, willingness had no effect on vaccine up-
take, while adequate promotion remains highly associated.
These results raise the issue of control, i.e. to what extent
are people truly in control of vaccination behavior if they
are depending on providers’ motivation and initiation? As
stated by Sheeran P. (2011), the gap between intention
and behavior is caused by those with high intention who
don’t act (inclined abstainers) and those with low inten-
tions who do act (disinclined actors) [27]. In the case of
this HPV vaccination pilot program, it seems that many
participants are inclined abstainers as a result of poor pro-
motion, i.e. they wished to vaccinate their daughter against
cervical cancer but were not well enough informed to do
so. On the other hand, we need to ask ourselves the ques-
tion how well people can express their wish and predict
their behavior in this context. Again, socially desirable an-
swers may have caused overestimation of willingness, but
there are many other factors [27] that may have led to ex-
pression of high interest and/or low uptake. Most partici-
pants had never heard of the HPV vaccine and 40 % had
never heard of cervical cancer. For them to process all in-
formation received during the baseline interview and im-
mediately report acceptability and intention to vaccinate
might have been difficult or unreliable (cognitive variables)
[27, 42]. In addition, the time-lapse between the first inter-
view and the start of the pilot program, might have given
participants time to overthink (temporal stability) and dis-
cuss cervical cancer vaccination with friends and family
(subjective norms). As a result, some participants might
have changed their opinion and preferred not to act [27,
37, 43]. Finally, other important activities (competing in-
tentions) might have inhibited participants from taking the
time to let their daughter get vaccinated against cervical
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cancer [27]. Given the harsh living circumstances of many
of our participants, other priorities are not unlikely.
The nine baseline HBM constructs, which only explained
8 % of the variance of uptake (Model 1), explained 41 % of
the variance of willingness. Given that willingness to
vaccinate was also measured at baseline (as opposed to
uptake at follow-up), it was expected to detect more cor-
relations among the cross-sectional data. Self-efficacy was
the strongest correlate, but also susceptibility was posi-
tively associated. Perceived vulnerability has been previ-
ously related with acceptability [10, 36] and uptake of
(preventive) behavior [16, 18–20], yet as described above,
we did not find the latter correlation. Finally, participants
who thought of their partner as somebody who would op-
pose to vaccinate their daughter against cervical cancer,
were less likely to accept the vaccine. Interventions should
target these characteristics and include all decision makers
as to increase the willingness to vaccinate.
Research objective 3: Influence of personal characteristics
in the HBM
Personal characteristics altered Model 3 and increased
the explained variance of willingness from 41 to 48 %
and of uptake from 47 to 52 %. However, given that only
acceptable goodness of fit was achieved, we merely con-
sider this as a sketch on how these variables are related
with HBM constructs, willingness and uptake as opposed
to an adapted version of the model. For example, aware-
ness had a direct impact on uptake which supports the
importance of cognitive variables: participants who had
heard of cervical cancer before baseline were more likely
to vaccinate their daughter. Whether the effect is a result
of knowledge of cervical cancer rather than the ability to
process the new information regarding the vaccine more
easily, is yet to be determined. Also, religion clearly af-
fected the HBM constructs: Muslims were more likely
to agree with the barriers ‘father’s refusal’ and ‘time
constraints’, were less likely to perceive cervical cancer
as severe, thought their daughter was less susceptible,
had lower self-efficacy, and were less driven by the fact
that the vaccine would protect their daughter’s health.
The underlying reasons, e.g. a more conservative attitude
or mistrust in the health system, are to be investigated
more in-depth. Finally, the positive effect of susceptibility
on willingness was higher for single mothers, and the
negative relation of perceiving the father as a barrier for
willingness weakened when the daughter was older. While
the former interaction might reveal a kind of freedom to
express intentions among women without a partner, the
latter hints that even though a partner may object,
mothers of older girls still intended to vaccinate, maybe
without his consent. Our results suggest that personal
characteristics influence vaccination differently in dif-
ferent circumstances, demonstrating the complexity of
the decision-making process regarding cervical cancer
vaccination. Further research is necessary to define whether
or not some of these variables would have an added value
to the HBM.
Conclusions
We found little support for the HBM in the context of
HPV vaccination in Kenya and neither was willingness a
good predictor for uptake. During the past few years, the
term vaccine hesitancy has popped up in vaccination
literature regarding reluctance towards immunization,
referring to “to delay in acceptance or refusal of vaccin-
ation despite availability of vaccination services”. Meas-
uring vaccine hesitancy, and its determinants vaccine
confidence, complacency and convenience, might offer
a better insight in the ‘state of preparedness’ and willing-
ness of people to vaccinate against cervical cancer as op-
posed to acceptability or intention to vaccinate, which are
now mostly used in formative research [44].
However, other longitudinal studies have equally showed
that attitudes, health beliefs and intentions are not always
strong correlates of HPV vaccination [37, 38, 45]. Reiter et
al. proclaim that “beliefs and attitudes may not be import-
ant determinants in the early adoption of behaviors that
are not well understood by most individuals” [37]. In the
same light and based on the strong correlation between ad-
equate promotion and vaccine uptake, we hypothesize that
supportive important others, motivation by health pro-
viders and general trust in the health system may be of ex-
treme importance to counteract knowledge gaps and
doubts. Therefore, we recommend to further study
whether interpersonal variables and variables at the level of
community or health system are (more) important deter-
minants of new (preventive) health actions as opposed to
personal beliefs [42, 46]. By monitoring future HPV vaccin-
ation programs and by assessing users’ and non-users’ per-
spectives these variables could be more explored and if
deemed appropriate added to the HBM. Furthermore, such
research could help identifying specific components of pro-
motion interventions necessary for the target group to per-
ceive promotion as adequate. Finally, our results also
encourage the examination of modifying effects of personal
characteristics since they might boost the predictive value
of the HBM. Identification of such determinants might
then help to increase the efficacy of future promotion
campaigns and as such, create awareness, consensus and
support for HPV vaccination at the community level.
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